Document:

Exhibit
      10.15

    TECHNOLOGY
      COOPERATIVE AGREEMENT

    

    

    This
      Technology Cooperative Agreement (this “Agreement”) is made effective as of
      March 24, 2006 (the “Effective Date”) by and between CASTion Corporation, a
      corporation organized and existing under the laws of Commonwealth of
      Massachusetts, having a principal address at 10 New Bond Street, Worcester,
      Massachusetts 01606 USA (“CASTion”) and ThermoEnergy Corporation, a corporation
      organized and existing under the laws of the State of Arkansas, having a
      principal address at 124 W. Capital Avenue, Suite 880, Little Rock, AR
      72201 (“ThermoEnergy”).

    

    WHEREAS,
      ThermoEnergy owns the exclusive worldwide rights to a certain patented ion
      exchange technology called the Ammonia Recovery Process (ARP) which it currently
      markets to municipal and industrial clients worldwide, and possesses proprietary
      engineering know-how and trade secrets related to the ARP technology
      (collectively, the “ThermoEnergy Technology”);

    

    WHEREAS,
      CASTion owns certain patent-pending R-CastTM brand technology and possesses
      proprietary engineering know-how and trade secrets (collectively, the “CASTion
      Technology”);

    

    WHEREAS,
      ThermoEnergy is looking for new ways to increase market share either through
      optimization of existing technology or finding new water treatment technologies
      to offer its clients;

    

    WHEREAS,
      ThermoEnergy and CASTion have determined that combining the ThermoEnergy
      Technology with the CASTion Technology (each independently a “System,” and each
      combination a “Combined System”) offers operational and economic advantages for
      certain potential clients greater than that of each System independently, and
      that CASTion has the ability to design, engineer and construct the System and
      Combined System;

    

    WHEREAS,
      ThermoEnergy and CASTion desire to enter into this Technology Cooperative
      Agreement whereby CASTion will supply the ThermoEnergy Technology, the CASTion
      Technology and the Combined System to ThermoEnergy to enable it to market to
      potential clients worldwide the Combined System on an exclusive basis, and
      the
      CASTion System on a non-exclusive basis;

    

    NOW,
      THEREFORE, for and in consideration of the promises contained herein, and for
      other good and valuable consideration, the receipt and adequacy of which it
      is
      hereby acknowledged, the parties hereto, intending to be legally bound, agree
      as
      follows:

    

    
      	
              1.

            	
              Systems
                Supply.
                ThermoEnergy shall fulfill all commercial contracts by purchasing
                either a
                System or a Combined System exclusively from CASTion subject to the
                terms
                and specifications set forth in a System Purchase Agreement (the
“System
                Purchase Agreement”), which the parties shall negotiate in good faith for
                execution prior to the date on which CASTion accepts the purchase
                order to
                which said System Purchase Agreement shall be
                attached.

            

    

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
 

    
      	
              2.

            	
              License
                to Construct and Fabricate.
                ThermoEnergy grants to CASTion, subject to the terms set forth in
                this
                Agreement, the right to construct and fabricate the ThermoEnergy
                Technology for the purpose of integrating it into the Combined System
                for
                sale to ThermoEnergy. ThermoEnergy represents and warrants that it
                shall
                provide to CASTion all information relating to the ThermoEnerngy
                Technology required by CASTion to perform its obligations under this
                Agreement.

            

    

    

    
      	
              3.

            	
              License
                to Recall.
                CASTion grants ThermoEnergy, subject to the terms set forth in this
                Agreement, an exclusive, nontransferable (except as provided in
                Section 7 herein), worldwide right and license, for the limited term
                specified in this Agreement, to use, demonstrate, and sell the Combined
                System, describe herein as supplied to it by CASTion, and a non-exclusive,
                nontransferable (except as provided in Section 7 herein), worldwide
                right and license, for the limited term specified in this Agreement,
                to
                use, demonstrate, and sell the CASTion System, described herein as
                supplied to it by CASTion.

            

    

    

    
      	
              4.

            	
              Ownership
                of Intellectual Property.
                For purposes of this Agreement, the System Sales Agreement, and the
                Non-Disclosure Agreements (the “NDA”) executed by and between the parties
                on or about August 25, 2003 and January 11, 2005, which
                agreements are incorporated herein and the non-disclosure obligations
                under which are hereby made perpetual, “Intellectual Property” means all
                rights of every nature relating to intellectual property, including
                without limitation (i) all United States and foreign patents and
                patent applications now or hereafter filed (including continuations,
                continuations-in-part, divisionals, reissues, reexaminations, and
                foreign
                counterparts thereof), and all rights with respect thereto, (ii) all
                trade secrets, (iii) all trademarks and trade names, and
                (iv) all copyrights and renewals
                thereof.

            

    

    

    
      	 	
              a.

            	
              ThermoEnergy
                Intellectual Property.
                All right, title and interest in and to the ThermoEnergy are and
                shall
                remain the sole and exclusive property of ThermoEnergy, subject to
                the
                rights and licenses granted herein. CASTion’s possession, installation, or
                use of the ThermoEnergy Technology does not transfer to CASTion any
                title
                to ThermoEnergy Intellectual Property, and CASTion shall not acquire
                any
                rights to the ThermoEnergy Intellectual Property except limited rights
                expressly set forth in this
                Agreement.

            

    

    

    
      	 	
              b.

            	
              CASTion
                Intellectual Property.
                All right, title and interest in and to the CAStion Technology, and
                any
                Intellectual Property developed by CASTion in the process of designing,
                manufacturing or testing the Combined Systems, are and shall remain
                the
                sole and exclusive property of CASTion, subject to the rights and
                licenses
                granted herein (collectively, the “CASTion Intellectual Property”).
                ThermoEnergy’s possession, installation, or use of the Combined System
                does not transfer to ThermoEnergy any title to CASTion Intellectual
                Property and ThermoEnergy shall not acquire any rights to the CASTion
                Intellectual Property except the limited rights expressly set forth
                in
                this Agreement.

            

    

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
 

    
      	
              5.

            	
              Term;
                Termination.
                This Agreement shall be effective as of the Effective Date and shall
                continue in effect for three (3) years, shall automatically renew for
                successive one (1) year terms thereafter unless terminated by either
                party in writing within sixty (60) days prior to the expiration of
                the then-current term. This Agreement may be terminated only if
                (i) the parties are unable to agree on mutually satisfactory terms to
                the System Sales Agreement, (ii) upon material breach Section 1,
                2, 3, or 4 of this Agreement, unless such breach of Section 1, 2, or
                3 is cured within thirty (30) days of receipt of written notice by
                the breaching party, or (iii) if either party should file for
                insolvency under the US Bankruptcy Protection Act. Upon termination,
                the
                licenses and rights granted herein shall expire immediately, and
                each
                party shall return to the other party any Confidential Information
                of the
                other in its possession. Sections 4 and 8 of this Agreement, the NDA,
                and those provisions of the System Sales Agreements required by the
                context, shall survive termination of this
                Agreement.

            

    

    

    
      	
              6.

            	
              Relationship
                of the Parties.
                CASTion and ThermoEnergy are independent contractors, and nothing
                in this
                Agreement shall be construed as making them partners or as creating
                the
                relationships of employer and employee, master and servant, or principal
                and agent between them, for any purpose whatsoever. Neither party
                shall
                make any contracts, warranties or representations or assume or create
                any
                other obligations, express or implied, in the other party’s name or on its
                behalf.

            

    

    

    
      	
              7.

            	
              Assignment.
                Neither party hereto shall (by operation of law or otherwise) assign,
                transfer or subcontract its rights or delegate its performance under
                this
                Agreement without the prior written consent of the other party hereto
                and
                any such assignment, transfer or delegation without such consent
                shall be
                void and of no force or effect; provided, however that either party
                hereto
                may assign all of its rights and obligations hereunder to a successor
                to
                all or substantially all of its business and assets (by acquisition,
                merger, sale of assets or otherwise) who accepts the terms of this
                Agreement in writing. Subject to the preceding sentence, this Agreement
                shall be binding upon, inure to the benefit of and be enforceable
                by the
                parties hereto and their respective successors and
                assigns.

            

    

    

    
      	
              8.

            	
              Governing
                Law and Forum.
                This Agreement shall be governed by the laws of the Commonwealth
                of
                Massachusetts without regard to choice of law principles; and each
                party
                irrevocably (i) agrees that any action proceeding arising from or
                relating to this Agreement may be brought only in the courts of
                Massachusetts or the U.S. District Court located in Boston, Massachusetts,
                (ii) consents, for itself and in respect of its property, to the
                jurisdiction of each such court in any such action or proceeding,
                and
                (iii) waives any objection to proceeding in such venue, including
                that the forum is inconvenient. The application of the U.N. Convention
                on
                Contracts for the International Sale of Goods is specifically excluded
                from this Agreement.

            

    

     

    
 

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    EACH
      PARTY ACKNOWLEDGES THAT IT HAS READ THIS AGREEMENT, UNDERSTANDS, AND AGREES
      TO
      BE BOUND BY ITS TERMS AND CONDITIONS.

     

     

    
      
        	CASTION
                CORPORATION	 	 	THERMOENERGY
                CORPORATION
	 	 	 	 
	 	 	 	 
	By:
                /s/
                Jeff Powell	 	 	By:
                /s/
                Dennis C. Cossey
	Jeff Powell
President &
                CEO	 	 	
                Dennis Cossey

                President & CEO

              
	
                 

                Date: March
                  24, 2006

              	 	 	
                Date: March
                  24, 2006EXHIBIT 10.10

                              SETTLEMENT AGREEMENT

THIS AGREEMENT ("Agreement"), dated this 20th day October 2005 (the "Execution
Date"), is entered into by and among SearchHelp, Inc., a Delaware corporation
("SHLP") and Bioneutral Laboratories Corporation USA, a Delaware corporation
("BNC"), with its principal address at P.O. Box 2131 Morristown, New Jersey
07962-2131. SHLP and BNC are hereinafter referred to individually as a "Party"
and collectively as the "Parties").

                                  INTRODUCTION:

This Agreement has been entered into with reference to the following:

      A.    On February 3, 2004, SHLP and BNC entered into a agreement whereby
            SHLP issued to BNC 1,725,000 shares of restricted common stock of
            SHLP and warrants to purchase an additional 1,725,000 shares. BNC is
            currently in possession of 2,822,727 shares, consisting of the
            1,725,000 shares issued to it on February 3, 2004 and 1,725,000
            warrants which it has converted, into an additional 1,097,727
            shares.

      B.    On February 3, 2004, SHLP and Environmental Commercial Technology
            Corp., a Delaware corporation ("ECT") entered into a Participation
            Agreement (the "Participation Agreement") whereby SHLP (i) agreed to
            pay ECT the sum of $600,000 in partial consideration for a portion
            of certain royalties which were expected to be received by ECT in
            conjunction with the sale, in the United States, of certain
            compounds (the "Compounds") to address certain conditions of mold
            and/or fungus infestation, $500,000 of which has been paid by
            SearchHelp. and (ii) issued to ECT 575,000 shares of restricted
            common stock of SHLP and warrants to purchase an additional 575,000
            shares. Subsequently, ECT distributed all of such shares and
            warrants to finders with respect to the transactions referred to in
            this Paragraph B and the foregoing Paragraph A of this Introduction.

      C.    As a part of the agreement, BNC was to have filed certain requests
            for registration with the United States Environmental Protection
            Agency (the "EPA") and to have conducted certain tests and received
            EPA approvals for the sale of the Compounds. No EPA registration has
            been filed by BNC or approved by the EPA as of the date of this
            Agreement.

      D.    SHLP has a liability in the amount of $100,000 which was due to ECT
            on August 5, 2004.

      E.    In November 2004, BNC acquired in excess of ninety percent (90%) of
            the outstanding common stock of ECT and caused it to be merged with
            a subsidiary of BNC, with the result being that ECT then became a
            wholly owned subsidiary of BNC.
<PAGE>

      NOW, THEREFORE, in consideration of the mutual covenants and agreements
contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the Parties agree as follows:

1.    Definitions. As used in this Agreement, the term "Person" shall mean and
include any one or more individual, corporation, partnership, limited liability
corporation, entity, trust, instrumentality or governmental authority. As used
here, the term "Affiliate" shall have the same meaning as is defined in Rule 405
promulgated under the Securities Act of 1933, as amended (the "Securities Act").

2.    Accuracy of Statements Contained in the Introduction. In addition to the
other representations and warranties made by one or more of the Parties that are
set forth elsewhere in this Agreement, it is expressly understood and agreed
that the accuracy of the statements set forth in the Introduction to this
Agreement (the "Introduction") constitutes the several representations and
warranties of the Parties and are incorporated herein by reference as though
recited in full.

3.    In consideration for SHLP's forbearance of legal recourse against BNC for
BNC's continuing delay in filing the EPA registration as recited in Paragraph C
of the Introduction, SHLP's liability in the amount of $100,000.00 under the
Participation Agreement, as recited in Paragraph D, of the Introduction, is
cancelled.

4.    SHLP hereby acknowledges and undertakes an obligation to pay to BNC a
total of $100,000.00, in two installments, each in the amount of $50,000.00
which shall be payable as follows:

      a.    Installment #1 on October 20th, 2006;
      b.    Installment #2 on October 20th, 2007.

5. BNC hereby covenants and agrees that it shall take all such steps as are
necessary to, and shall file an application with the EPA for approval of the
Compounds and shall diligently pursue and prosecute its application with the EPA
and shall render written quarterly reports to SHLP of the progress of the
application.

6.    (a) Upon filing of the application with the EPA, BNC shall provide to SHLP
written notice of the filing and a copy of the application. Unless SHLP notifies
BNC in writing within fifteen (15) days of the date of BNC's notice that the
application is not in proper form or, in the reasonable opinion of counsel to
SHLP, does not comply with the EPA's requirements for such Compounds intended to
be used in the remediation of mold and/or fungus, SHLP shall accelerate the
payment of Installment #1 such that it shall be payable thirty (30) days after
the date of BNC's notice.

      (b) Upon approval of the application by the EPA, BNC shall provide to SHLP
written notice of the approval and a copy of the approval. Unless SHLP notifies
BNC in writing within fifteen (15) days of the date of BNC's notice that the
approval does not substantially correspond with the terms of the application,
SHLP shall accelerate the payment of Installment #2 such that it shall be
payable thirty (30) days after the date of BNC's notice. This Paragraph 6(b)
shall not be applicable if SHLP has provided the notice called for by Paragraph
6(a) and the application has not been amended or if SHLP objects, pursuant to
Paragraph 6(a), to such amendment.

                                                                               2
<PAGE>

      (c) In the event that SHLP provides one or both of the notices called for
in Paragraphs 6(a) and (b) and SHLP's objection is subsequently resolved, the
respective Installment(s) shall be accelerated such that they shall be payable
thirty (30) days after such resolution unless such resolution necessitates the
filing of an amended or new application.

7.    BNC hereby grants to SHLP, and SHLP hereby accepts, a participation
interest with economic benefits identical (except as specified below) to the
participation interest granted by ECT under the Participation Agreement. Such
participation interest granted by BNC shall be in substitution for (and not in
addition to) SHLP's participation interest under the Participation Agreement.
Notwithstanding the foregoing, the participation interest granted by BNC
hereunder shall be applicable to Gross Sales, as that term is defined in the
Participation Agreement, in all parts of the world where BNC is not prohibited
from selling products containing the Compounds. For purposes of clarification,
the foregoing grant by BNC of a participation interest with a geographic scope
greater than that in the Participation Agreement shall not affect any other
terms of the definition of Gross Sales, including, for example, the limitation
upon the applicability of such participation interest to sales of products
containing the Compounds where the "stated use" (i.e., the principal application
of the product as stated on the label, packaging or other printed material
furnished with the product) is principally to control, remediate, abate or
otherwise affect mold or fungus.

8.    SHLP share ownership by BNC

      (a) The Parties stipulate that BNC currently owns 300,227 shares of the
common stock of SHLP (the "Retained Shares"). BNC acquired the Retained Shares
by exercising a warrant that it acquired from SHLP in a transaction that
occurred on February 4, 2004. In acquiring the Retained Shares, no consideration
was given by BNC in connection with the exercise of such warrant, other than the
surrender by BNC of rights under of such warrant to purchase a number of shares
having a fair market value equal to the aggregate exercise price of such
warrant.

      (b) SHLP hereby grants piggyback registration rights to BNC with respect
to the Retained Shares as follows: SHLP shall, at the request of BNC, include
the Retained Shares in any registration statement (other than a registration
statement on Form S-8) filed by SHLP with the Securities and Exchange Commission
after the date hereof and shall maintain the effectiveness of such statement
until all of the Retained Shares have been sold by BNC.

      (c) BNC hereby agrees that, until March 1, 2006, BNC will not, without the
prior written consent of SHLP, sell any of the Retained Shares except in one or
more direct private transactions (i.e., transactions not involving the OTC
Bulletin Board or any other electronic quotation service). The foregoing
restriction shall be of no further force or effect if a registration statement
has been declared effective with respect to the Retained Shares. SHLP hereby
consents to the transfer by BNC of up to 12,500 of the Retained Shares in
connection with pre-existing contractual obligations of BNC.

                                                                               3
<PAGE>

9.    Miscellaneous.

      (a) Entire Agreement. This Agreement contains the entire agreement between
the Parties hereto with respect to the subject matter hereof. This Agreement may
not be amended or revised except by a writing signed by the Party to be charged
with enforcement.

      (b) Binding Effect; Assignment. This Agreement shall be binding upon and
inure to the benefit of the Parties hereto and their respective successors and
permitted assigns. None of the rights or obligations set forth in this Agreement
may be assigned by any Party to any other Person, without the prior written
consent of the other Party. (c) Survival. The covenants and agreements of the
Parties set forth in this Agreement shall survive indefinitely the consummation
of the transactions contemplated hereby.

      (d) Separate Counterparts. This Agreement may be executed in counterparts,
each of which when so executed shall constitute an original and all of which
when taken together shall constitute but one instrument. A telephone line
facsimile transmission of this Agreement bearing a signature on behalf of a
Party hereto shall be legal and binding on such Party.

      (e) Expenses. Each of the Parties agrees to pay their respective costs and
expenses in connection with the negotiation and execution of this Agreement.

      (f) Cumulative Remedies. The remedies of the Parties hereunder shall be
cumulative, and the exercise by any of the Parties of any of its remedies at law
or in equity to recover any damages shall not affect any other remedy available
to such Party or Parties and the exercise by any Party or Parties of any of its
remedies at law or in equity to recover any damages shall not affect any other
remedy available to such Party or Parties.

      (g) Notices. Except as otherwise expressly provided herein, all notices
hereunder, to be effective, shall be in writing and shall be mailed by certified
mail, postage and fees prepaid, or delivered personally or by telephone line
facsimile transmission to the Party to be notified as set forth on the signature
pages of this Agreement, and shall be effective on receipt. A Party may change
the address to which such communications are to be directed to it by giving
written notice to the other Parties hereto of such change in the manner above
provided. Copies of all notices shall be sent to counsel to the respective
Parties, but such copies shall not constitute notice.

      (h) Severability. The provisions of this Agreement are severable, and the
invalidity of any provision shall not affect the validity of any other
provision.

                                                                               4
<PAGE>

      (i) No Waiver. The failure of a Party at any time or times to require
performance of any provision hereof shall in any manner affect its right at a
later time to enforce the same. No waiver by a Party of any condition, or of the
breach of any term, covenant, representation, warranty or agreement contained in
this Agreement, whether by conduct or otherwise, in any one or more instances
shall be deemed to be or construed as a further or continuing waiver of any such
condition or breach or a waiver of any other condition or of the breach of any
other term, covenant, representation, warranty or agreement contained in this
Agreement.

      (j) Reviewed by Attorneys. Each of the Parties represents to all other
Parties that he or it (A) understands fully the terms of this Agreement and the
consequences of the execution and delivery of this Agreement, (B) has been
afforded an opportunity to have this Agreement reviewed by, and to discuss this
Agreement and document executed in connection herewith with, such attorneys and
other persons as such Party may wish, and (C) has entered into this Agreement
and executed and delivered all documents in connection herewith of his or its
own free will and accord and without threat, duress or other coercion of any
kind by any person or entity. The Parties hereto acknowledge and agree that
neither this Agreement nor the other documents executed pursuant hereto shall be
construed more favorably in favor of one than the other based upon which Party
or which Party's counsel drafted the same, it being acknowledged that all
Parties hereto contributed substantially to the negotiation and preparation of
this Agreement and the other documents executed pursuant hereto or in connection
herewith.

      (k) Governing Law; Consent to Jurisdiction and Process; Waiver of Jury
Trial; Process Agents. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York. THE PARTIES HERETO CONSENT TO
THE JURISDICTION OF THE STATE AND FEDERAL COURTS LOCATED IN THE STATE OF NEW
YORK, SITTING IN THE COUNTY OF NEW YORK AND FURTHER CONSENT THAT ANY PROCESSOR
NOTICE OR OTHER APPLICATION TO ANY COURT OR A JUDGE THEREOF MAY BE SERVED WITHIN
OR WITHOUT THE STATE OF NEW YORK BY CERTIFIED MAIL OR BY PERSONAL SERVICE,
PROVIDED A REASONABLE TIME FOR APPEARANCE IS ALLOWED. EACH PARTY HERETO HEREBY
WAIVES ITS RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY LEGAL PROCEEDING ARISING
OUT OF OR IN CONNECTION WITH THIS AGREEMENT.

      (l) Headings. The Article and Section headings, captions, headers and
footers contained in this Agreement are for convenience only and shall not form
part of or affect the interpretation of this Agreement.

      (m) Further Assurances. Each Party to this Agreement will perform any and
all acts and execute any and all documents as may be reasonably necessary and
proper under the circumstances in order to accomplish the intents and purposes
of this Agreement and to carry out its provisions.

                [Remainder of This Page Intentionally Left Blank]

                                                                               5

<PAGE>

      IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be
duly executed by their respective representatives thereunto duly authorized, as
of the date first above written.

                           SEARCHHELP, INC

                           By:    ___________________
                           Name:  ___________________
                           Title: ___________________

                           Bioneutral Laboratories Corporation USA

                           By:    ___________________
                           Name:  ___________________
                           Title: ___________________

Consented and agreed (with respect to Paragraph 3 only):

Environmental Commercial Technology Corp.

By:      ______________________
Name:    ______________________
Title:   ______________________

                                                                               6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00102-of-00352.parquet"}]]